Administration & Agency Updates

Recent Administration & Agency Updates

  • May 4, 2021·

FCC COVID-19 Telehealth Funding Applications Due May 6

On April 29, the Federal Communications Commission (FCC) opened Round 2 of the FCC COVID-19 Telehealth Program. The program supports eligible health care providers (HCPs) responding to the pandemic by fully funding their telecommunications services, information services, and connected devices necessary to provide telehealth and connected care services. Funding may be retroactive for services and devices purchased since March 13, 2020. The deadline to apply is May 6. What can…
Learn More
  • April 28, 2021·

Indian Health Service Update on Johnson & Johnson/Janssen Vaccine

On Friday, April 23, at the recommendation of the Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC) the Indian Health Service (IHS) has lifted its pause of Johnson & Johnson/Janssen COVID-19 vaccine administration. Indian Health Service facilities will resume administering the Johnson & Johnson/Janssen COVID-19 vaccine. IHS originally paused administration of the Johnson & Johnson/Janssen COVID-19 vaccine to allow the FDA and CDC to review…
Learn More
  • April 16, 2021·

White House Releases Dear Tribal Leader on American Rescue Plan Funding to Indian Country

On April 16, the White House released a Dear Tribal Leader outlining the over $4 Billion in funding provided to Indian Country in the American Rescue Plan to combat COVID-19. The letter highlights: $600 Million to increase COVID-19 vaccinations in Indian Country $1 billion to detect, diagnose, trace, monitor, and mitigate COVID-19 infections $2 billion for tribal health systems due to lost reimbursements for…
Learn More
  • April 15, 2021·

Announcement of Pause in Use of Johnson & Johnson/Janssen Vaccine

On April 13, the Centers for Disease Control and Prevention (CDC) and Food and Drug Administration recommended that all hospitals, clinics, and other providers sites, including Indian Health Service (IHS) and Tribal health facilities and clinics, pause the use of the Johnson & Johnson’s Janssen COVID-19 vaccine due to reports of adverse events. In the United States, there have been six reported cases of a rare…
Learn More
  • March 8, 2021·

CDC Issues First Set of Guidelines on How Fully Vaccinated People Can Visit Safely with Others

On Monday, March 8, 2021, the Centers for Disease Control and Prevention (CDC) issued its first set of recommendations on activities that people who are fully vaccinated against COVID-19 can safely resume. The new guidance—which is based on the latest science — includes recommendations for how and when a fully vaccinated individual can visit with other people who are fully vaccinated and with other…
Learn More
  • March 1, 2021·

FDA Issues Emergency Use Authorization for Janssen COVID-19 Vaccine

On February 27, Food and Drug Administration (FDA) approved an Emergency Use Authorization (EUA) for the Janssen (Johnson & Johnson) COVID-19 Vaccine and on February 28, Janssen’s single-dose COVID-19 vaccine was unanimously recommended by the Center for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices. Important information about the Janssen (J&J) vaccine: 66.1% effective in preventing moderate to severe COVID-19 infections 85.4% effective against severe or…
Learn More

Contact Us

To reach the NIHB COVID-19 Response Team, please contact [email protected].

For media inquiries, please contact April Hale at [email protected].

Facebook Twitter Instagram Youtube

© Copyright 2020, National Indian Health Board. All Rights Reserved. Website by DrawBridge Creative.

Privacy Policy

This website is supported by the Centers for Disease Control and Prevention of the U.S. Department of Health and Human Services (HHS) as part of a financial assistance award totaling $2,000,000 with 70 percent funded by CDC/HHS, and 30 percent funded by non-government source(s). The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by CDC/HHS, or the U.S. Government.